Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis SA’s acquisition of Cerbios-Pharma SA, marking its first deal in Europe.
Source link
2025-03-30
Welcome
Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis SA’s acquisition of Cerbios-Pharma SA, marking its first deal in Europe.
Source link
Privacy Policy Designed using Magazine News Byte. Powered by WordPress.